Objectives To identify the source of postnatal colonization with group B Streptococcus (GBS)
and to evaluate the impact of intrapartum antibiotic prophylaxis (IAP) administration in …

Objectives To assess the incidence of colonization with group B streptococci (GBS) among
neonates as influenced by maternal GBS carriage and intrapartum antibiotic prophylaxis …

Objectives. To define factors influencing vertical transmission of and neonatal colonization
with group B streptococci (GBS) in neonates representing ethnically and economically …

Background: Data regarding the minimum duration of intrapartum antibiotic prophylaxis
(IAP) required for preventing group B Streptococcus (GBS) early-onset sepsis are conflicting …

Group B Streptococcus (GBS) is the most frequent cause of early onset of neonatal sepsis.
Case-fatality rate is 6-20% for newborns. Neurological sequel occurs in 30% of survivors. In …

Background: Streptococcus agalactiae (group B Streptococcus, GBS) is the most common
cause of early neonatal infection, but restricting the diagnosis to culture-positive infants may …

The burden of early onset neonatal sepsis due to group B Streptococcus (GBS) has declined
substantially over the past 20 years as a result of widespread use of intrapartum antibiotic …

Background: Most early-onset group B streptococcal (GBS) disease in recent years has
occurred in newborns of prenatally GBS-negative mothers who missed intrapartum antibiotic …

Objective. Intrapartum antibiotic prophylaxis (IAP) in mothers with group B streptococcus
(GBS) colonization presents difficult neonatal management decisions. IAP was instituted in …

Objectives/Study design Administration of group B streptococcal (GBS) antibiotic prophylaxis
to women in labor has dramatically reduced the incidence of GBS neonatal disease, but …